Erratum: CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991))

Bruce Ruggeri; Jasbir Singh; Diane Gingrich; Thelma Angeles; Mark Albom; Shi Yang; Hong Chang; Candy Robinson; Kathryn Hunter; Pawel Dobrzanski; Susan Jones-Bolin; Sonya Pritchard; Lisa Aimone; Andres Klein-Szanto; Jean Marc Herbert; Francoise Bono; Paul Schaeffer; Pierre Casellas; Bernard Bourie; Roberto Pili; John Isaacs; Mark Ator; Robert Hudkins; Jeffrey Vaught; John Mallamo; Craig Dionne

Erratum: CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991))

Bruce Ruggeri
, Jasbir Singh
, Diane Gingrich
, Thelma Angeles
, Mark Albom
, Shi Yang
, Hong Chang
, Candy Robinson
, Kathryn Hunter
, Pawel Dobrzanski
, Susan Jones-Bolin
, Sonya Pritchard
, Lisa Aimone
, Andres Klein-Szanto
, Jean Marc Herbert
, Francoise Bono
, Paul Schaeffer
, Pierre Casellas
, Bernard Bourie
, Roberto Pili

John Isaacs, Mark Ator, Robert Hudkins, Jeffrey Vaught, John Mallamo, Craig Dionne

Medicine

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	7543
Number of pages	1
Journal	Cancer Research
Volume	63
Issue number	21
State	Published - Nov 1 2003

Fingerprint

Dive into the research topics of 'Erratum: CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991))'. Together they form a unique fingerprint.

Cite this

Ruggeri, B., Singh, J., Gingrich, D., Angeles, T., Albom, M., Yang, S., Chang, H., Robinson, C., Hunter, K., Dobrzanski, P., Jones-Bolin, S., Pritchard, S., Aimone, L., Klein-Szanto, A., Herbert, J. M., Bono, F., Schaeffer, P., Casellas, P., Bourie, B., ... Dionne, C. (2003). Erratum: CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991)). Cancer Research, 63(21), 7543.

@article{c8fec04fee224ad086b2ca8470e47058,

title = "Erratum: CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991))",

author = "Bruce Ruggeri and Jasbir Singh and Diane Gingrich and Thelma Angeles and Mark Albom and Shi Yang and Hong Chang and Candy Robinson and Kathryn Hunter and Pawel Dobrzanski and Susan Jones-Bolin and Sonya Pritchard and Lisa Aimone and Andres Klein-Szanto and Herbert, \{Jean Marc\} and Francoise Bono and Paul Schaeffer and Pierre Casellas and Bernard Bourie and Roberto Pili and John Isaacs and Mark Ator and Robert Hudkins and Jeffrey Vaught and John Mallamo and Craig Dionne",

year = "2003",

month = nov,

day = "1",

language = "English",

volume = "63",

pages = "7543",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "21",

}

Ruggeri, B, Singh, J, Gingrich, D, Angeles, T, Albom, M, Yang, S, Chang, H, Robinson, C, Hunter, K, Dobrzanski, P, Jones-Bolin, S, Pritchard, S, Aimone, L, Klein-Szanto, A, Herbert, JM, Bono, F, Schaeffer, P, Casellas, P, Bourie, B, Pili, R, Isaacs, J, Ator, M, Hudkins, R, Vaught, J, Mallamo, J & Dionne, C 2003, 'Erratum: CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991))', Cancer Research, vol. 63, no. 21, pp. 7543.

Erratum: CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991)). / Ruggeri, Bruce; Singh, Jasbir; Gingrich, Diane et al.
In: Cancer Research, Vol. 63, No. 21, 01.11.2003, p. 7543.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991))

AU - Ruggeri, Bruce

AU - Singh, Jasbir

AU - Gingrich, Diane

AU - Angeles, Thelma

AU - Albom, Mark

AU - Yang, Shi

AU - Chang, Hong

AU - Robinson, Candy

AU - Hunter, Kathryn

AU - Dobrzanski, Pawel

AU - Jones-Bolin, Susan

AU - Pritchard, Sonya

AU - Aimone, Lisa

AU - Klein-Szanto, Andres

AU - Herbert, Jean Marc

AU - Bono, Francoise

AU - Schaeffer, Paul

AU - Casellas, Pierre

AU - Bourie, Bernard

AU - Pili, Roberto

AU - Isaacs, John

AU - Ator, Mark

AU - Hudkins, Robert

AU - Vaught, Jeffrey

AU - Mallamo, John

AU - Dionne, Craig

PY - 2003/11/1

Y1 - 2003/11/1

UR - https://www.scopus.com/pages/publications/0242694846

M3 - Comment/debate

AN - SCOPUS:0242694846

SN - 0008-5472

VL - 63

SP - 7543

JO - Cancer Research

JF - Cancer Research

IS - 21

ER -

Erratum: CEP-7055: A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models (Cancer Research (September 15, 2003) (5978-5991))

Other files and links

Fingerprint

Cite this